Surgery and weight-loss drugs are not a sign that willpower failed; they are legitimate options once the criteria are met. Under the 2022 ASMBS/IFSO standard, metabolic and bariatric surgery is recommended at a BMI of 35 or more and should be considered at 30–34.9 with metabolic disease; for Asian people the thresholds are lower, and surgery should be offered from a BMI of 27.5.